Sulfur and sodium sulfacetamide for rosacea: the older topicals that still earn a place

Ask about rosacea topicals today and you will hear the modern trio: metronidazole, azelaic acid, and ivermectin. Decades before any of them, dermatologists were writing prescriptions for sodium sulfacetamide and sulfur, and that combination has never entirely left the shelf. It is worth knowing what it is and where it still fits, because for a subset of patients it remains a genuinely useful tool.

What the combination is. The classic formulation pairs 10 percent sodium sulfacetamide with 5 percent sulfur, dispensed as a wash, cleanser, cream, or lotion. Sodium sulfacetamide is a sulfonamide with antibacterial and anti-inflammatory effects; sulfur is a mild keratolytic and antimicrobial that also has some activity against the Demodex mites that proliferate in rosacea skin. Between them, the pair addresses several of the pathways thought to drive the inflammatory bumps. The American Academy of Dermatology includes sulfacetamide-sulfur among the topical options dermatologists use for rosacea.

What the evidence shows. The supporting trials are real but older, mostly from the 1980s and 1990s, and they report meaningful reductions in inflammatory papules, pustules, and redness in papulopustular rosacea. By modern standards those studies were small and less rigorously designed than the trials behind ivermectin or azelaic acid, which is a large part of why the newer agents are first-line today. The literature is collected on PubMed. The honest summary: it works for many people, but the evidence base is thinner and dustier than what backs the current favorites.

Where it fits today. Mostly as a second choice or an add-on. Dermatologists reach for it when a first-line topical irritates or underperforms, when cost or availability is an issue, or when they want a rinse-off format: a sulfacetamide-sulfur wash used once daily is a gentler introduction than a leave-on cream for very reactive skin. Its most distinctive niche is the patient whose central face carries both rosacea and seborrheic dermatitis, a common overlap we describe in our guide to telling facial redness apart, because the combination has a track record against both conditions at once.

The cautions. The important one is allergy: sodium sulfacetamide is a sulfonamide, so anyone with a sulfa antibiotic allergy should not use it, and that history belongs in the conversation before the prescription is written. Sulfur also has a faint characteristic smell that modern formulations mask reasonably well but not perfectly. Dryness and mild stinging are the common tolerability complaints, which is why the product should sit inside the same gentle, barrier-first routine that supports any rosacea treatment. And like every topical, it treats bumps and inflammation, not the fixed background vessels, which remain the territory of laser and light.

The takeaway is unglamorous and useful. Sulfacetamide-sulfur is an older, modestly supported, inexpensive option that still earns its place for irritated skin that cannot tolerate first-line topicals, and especially for the rosacea and seborrheic dermatitis overlap. If your current topical is not working or not agreeing with you, it is a reasonable name to raise with your dermatologist rather than a relic to dismiss.

Related reading: Topical treatments for rosacea that actually work and Rosacea, acne, or seborrheic dermatitis? Telling facial redness apart.